Lauren Bonnette, MD
Obstetrics & Gynecology · Rayville, LANPI 1538450317
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $736 of the $836 with a category attached, or 88.0%. It is spread thinly across 13 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $235 and has fallen 93.3% since, to $16 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in LA, where the typical reported total is $1,022.
Across 51 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$149
- Astellas Pharma US Inc$135
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$115
- Pfizer$92
- Johnson & Johnson$81
- Daiichi Sankyo Inc.$74
- plus $192 from 7 others
What the payments were for
- Food & beverage$73688%
- Education$10012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $149 |
| Astellas Pharma US Inc | 3 | $135 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $115 |
| Pfizer | 6 | $92 |
| Johnson & Johnson | 5 | $81 |
| Daiichi Sankyo Inc. | 4 | $74 |
| AbbVie | 5 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Novartis | 2 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $14 |
How this compares
$836 in reported general payments places this provider in the 45th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $2,744 |
| Estradiol (Once Weekly)Estradiol | 27 | $1,185 |
| Medroxyprogesterone Acetate | 122 | $1,006 |
| ProgesteroneProgesterone, Micronized | 12 | $299 |
| Clobetasol Propionate | 11 | $173 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $120 |
| Metronidazole | 19 | $107 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Rayville
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
- Earl PeeperNew Orleans$95K
- Thomas PayneBaton Rouge$84K
- Catherine VanderloosShreveport$55K
- George MorrisNew Orleans$34K
- Russell PhelpsLafayette$31K
- Rachelle MeauxLafayette$31K
- Leonard BlantonBossier City$28K
- Janifer TropezNew Orleans$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.